Cold Atmospheric Pressure Plasma-Activated Medium Modulates Cellular Functions of Human Mesenchymal Stem/Stromal Cells In Vitro.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
01 May 2024
Historique:
received: 22 03 2024
revised: 24 04 2024
accepted: 26 04 2024
medline: 11 5 2024
pubmed: 11 5 2024
entrez: 11 5 2024
Statut: epublish

Résumé

Cold atmospheric pressure plasma (CAP) offers a variety of therapeutic possibilities and induces the formation of reactive chemical species associated with oxidative stress. Mesenchymal stem/stromal cells (MSCs) play a central role in tissue regeneration, partly because of their antioxidant properties and ability to migrate into regenerating areas. During the therapeutic application, MSCs are directly exposed to the reactive species of CAP. Therefore, the investigation of CAP-induced effects on MSCs is essential. In this study, we quantified the amount of ROS due to the CAP activation of the culture medium. In addition, cell number, metabolic activity, stress signals, and migration were analyzed after the treatment of MSCs with a CAP-activated medium. CAP-activated media induced a significant increase in ROS but did not cause cytotoxic effects on MSCs when the treatment was singular and short-term (one day). This single treatment led to increased cell migration, an essential process in wound healing. In parallel, there was an increase in various cell stress proteins, indicating an adaptation to oxidative stress. Repeated treatments with the CAP-activated medium impaired the viability of the MSCs. The results shown here provide information on the influence of treatment frequency and intensity, which could be necessary for the therapeutic application of CAP.

Identifiants

pubmed: 38732164
pii: ijms25094944
doi: 10.3390/ijms25094944
pii:
doi:

Substances chimiques

Plasma Gases 0
Reactive Oxygen Species 0
Culture Media 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Union and the Federal State Mecklenburg-Vorpommern, EFRE
ID : TBI-V-1-336-VBW-116

Auteurs

Olga Hahn (O)

Institute of Cell Biology, Rostock University Medical Center, 18057 Rostock, Germany.

Tawakalitu Okikiola Waheed (TO)

Institute of Cell Biology, Rostock University Medical Center, 18057 Rostock, Germany.

Kaarthik Sridharan (K)

Institute of Cell Biology, Rostock University Medical Center, 18057 Rostock, Germany.

Thomas Huemerlehner (T)

Institute of Cell Biology, Rostock University Medical Center, 18057 Rostock, Germany.

Susanne Staehlke (S)

Institute of Cell Biology, Rostock University Medical Center, 18057 Rostock, Germany.

Mario Thürling (M)

Microfluidics, Faculty of Mechanical Engineering and Marine Technology, University of Rostock, 18059 Rostock, Germany.

Lars Boeckmann (L)

Clinic and Polyclinic for Dermatology and Venerology Rostock, Rostock University Medical Center, 18057 Rostock, Germany.

Mareike Meister (M)

Leibniz-Institute for Plasma Science and Technology e.V., 17489 Greifswald, Germany.

Kai Masur (K)

Leibniz-Institute for Plasma Science and Technology e.V., 17489 Greifswald, Germany.

Kirsten Peters (K)

Institute of Cell Biology, Rostock University Medical Center, 18057 Rostock, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH